Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Impax Laboratories Inc (IPXL)  
$6.89 0.11 (1.57%) as of 4:30 Fri 6/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 159,210,000
Market Cap: 1.10(B)
Last Volume: 2,204,422 Avg Vol: 2,198,459
52 Week Range: $2.7 - $7.11
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company engaging in developing, manufacturing, marketing and distributing generic and branded pharmaceutical products across an array of dosage forms and therapeutic areas. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 531
  Page 13 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Fleming Nigel Director   –       •      –    2012-08-13 4 AS $23.91 $143,460 D/D (6,000) 1,999     -
   Benet Leslie Z Director   –       •      –    2012-08-13 4 AS $23.96 $31,148 D/D (1,300) 6,200     -
   Benet Leslie Z Director   –       •      –    2012-08-10 4 GD $0.00 $0 D/D 2,255 7,500     -
   Burr Robert L Director   –       •      –    2012-08-08 4 AS $23.80 $35,700 D/D (1,500) 56,125     -
   Fleming Nigel Director   –       •      –    2012-08-06 4 AS $23.92 $159,448 D/D (6,667) 7,999     -
   Schlossberg Mark A SVP and General Counsel   •       –      –    2012-07-08 4 D $20.25 $55,708 D/D (2,751) 35,916     -
   Reasons Bryan M. Acting Chief Financial Officer   •       –      –    2012-06-29 3 IO $0.00 $0 D/D 0 12,600     -
   Nestor Michael President, Impax Pharm. Div.   •       –      –    2012-06-06 4 D $20.84 $57,331 D/D (2,751) 66,123     -
   Nestor Michael President, Impax Pharm. Div.   •       –      –    2012-05-26 4 D $21.23 $25,327 D/D (1,193) 68,874     -
   Hsu Larry President and CEO   •       •      –    2012-05-26 4 D $21.23 $113,984 D/D (5,369) 546,060     -
   Koch Arthur A Jr EVP, Finance, and CFO   •       –      –    2012-05-26 4 D $21.23 $31,463 D/D (1,482) 142,415     -
   Terreri Peter R Director   –       •      –    2012-05-23 4 A $0.00 $0 D/D 4,000 26,767     -
   Markbreiter Michael Director   –       •      –    2012-05-23 4 A $0.00 $0 D/D 4,000 14,666     -
   Chao Allen Director   –       •      –    2012-05-23 4 A $0.00 $0 D/D 4,000 47,095     -
   Burr Robert L Director   –       •      –    2012-05-23 4 A $0.00 $0 D/D 4,000 57,625     -
   Fleming Nigel Director   –       •      –    2012-05-23 4 A $0.00 $0 D/D 4,000 14,666     -
   Schlossberg Mark A SVP and General Counsel   •       –      –    2012-05-23 4 A $0.00 $0 D/D 8,667 38,667     -
   Nestor Michael President, Impax Pharm. Div.   •       –      –    2012-05-23 4 A $0.00 $0 D/D 13,000 70,067     -
   Koch Arthur A Jr EVP, Finance, and CFO   •       –      –    2012-05-23 4 A $0.00 $0 D/D 13,000 143,897     -
   Ben-Maimon Carole President, Global Pharm. Div.   •       –      –    2012-05-23 4 A $0.00 $0 D/D 4,333 28,333     -
   Nestor Michael President, Impax Pharm. Div.   •       –      –    2012-05-20 4 D $20.97 $25,017 D/D (1,193) 57,067     -
   Koch Arthur A Jr EVP, Finance, and CFO   •       –      –    2012-05-20 4 D $20.97 $212,783 D/D (10,147) 130,897     -
   Hsu Larry President and CEO   •       •      –    2012-05-20 4 D $20.97 $337,722 D/D (16,105) 505,429     -
   Nestor Michael President, Impax Pharm. Div.   •       –      –    2012-05-11 4 D $22.00 $26,246 D/D (1,193) 58,260     -
   Koch Arthur A Jr EVP, Finance, and CFO   •       –      –    2012-05-11 4 D $22.00 $32,604 D/D (1,482) 141,044     -
  531 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 13 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us